{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:20:07Z","timestamp":1760242807507,"version":"build-2065373602"},"reference-count":60,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T00:00:00Z","timestamp":1467676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>For more than a decade, stem cell therapy has been the focus of intensive efforts for the treatment of adult heart disease, and now has promise for treating the pediatric population. On the basis of encouraging results in the adult field, the application of stem cell-based strategies in children with congenital heart disease (CHD) opens a new therapy paradigm. To date, the safety and efficacy of stem cell-based products to promote cardiac repair and recovery in dilated cardiomyopathy and structural heart disease in infants have been primarily demonstrated in scattered clinical case reports, and supported by a few relevant pre-clinical models. Recently the TICAP trial has shown the safety and feasibility of intracoronary infusion of autologous cardiosphere-derived cells in children with hypoplastic left heart syndrome. A focus on preemptive cardiac regeneration in the pediatric setting may offer new insights as to the timing of surgery, location of cell-based delivery, and type of cell-based regeneration that could further inform acquired cardiac disease applications. Here, we review the current knowledge on the field of stem cell therapy and tissue engineering in children with CHD, and discuss the gaps and future perspectives on cell-based strategies to treat patients with CHD.<\/jats:p>","DOI":"10.3390\/jcdd3030024","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T10:06:19Z","timestamp":1467713179000},"page":"24","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stem Cell Therapy and Congenital Heart Disease"],"prefix":"10.3390","volume":"3","author":[{"given":"Timothy","family":"Nelson","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Transplant Center, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Center for Regenerative Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Cantero Peral","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Center for Regenerative Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease","volume":"39","author":"Hoffman","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/heartjnl-2012-302543","article-title":"Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: A population-based study","volume":"98","author":"Khoshnood","year":"2012","journal-title":"Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cardfail.2012.03.001","article-title":"Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: A population-based study","volume":"18","author":"Rossano","year":"2012","journal-title":"J. Card. Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00395-012-0252-x","article-title":"Pressure overload leads to an increase of cardiac resident stem cells","volume":"107","author":"Rupp","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/pr.2011.61","article-title":"Stem cell therapy for cardiac disease","volume":"71","author":"Bernstein","year":"2012","journal-title":"Pediatr. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCINTERVENTIONS.113.001009","article-title":"Intracoronary stem cell infusion after acute myocardial infarction: A meta-analysis and update on clinical trials","volume":"7","author":"Houtgraaf","year":"2014","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/eurheartj\/eht372","article-title":"Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: A collaborative meta-analysis","volume":"35","author":"Delewi","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.116.304346","article-title":"Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data","volume":"116","author":"Gyongyosi","year":"2015","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.111.086074","article-title":"Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: A systematic review and meta-analysis","volume":"126","author":"Jeevanantham","year":"2012","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jacc.2007.07.041","article-title":"Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials","volume":"50","author":"Lipinski","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/ehn220","article-title":"Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review","volume":"29","author":"Brunskill","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.hlc.2012.06.024","article-title":"Intracoronary infusion of bone marrow-derived mononuclear cells contributes to longstanding improvements of left ventricular performance and remodelling after acute myocardial infarction: A meta-analysis","volume":"21","author":"Ye","year":"2012","journal-title":"Heart Lung Circ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/clc.20745","article-title":"Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: Insights from randomized controlled trials with 12 or more months follow-up","volume":"33","author":"Zhang","year":"2010","journal-title":"Clin. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/eurjhf\/hfr148","article-title":"Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: A meta-analysis of randomized control trials","volume":"14","author":"Zimmet","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/01.CIR.0000043246.74879.CD","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)","volume":"106","author":"Assmus","year":"2002","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2004.08.014","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial","volume":"44","author":"Schachinger","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months\u2019 follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16698","DOI":"10.1073\/pnas.0905245106","article-title":"Modeling early retinal development with human embryonic and induced pluripotent stem cells","volume":"106","author":"Meyer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/hrt.2005.085431","article-title":"Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI)","volume":"92","author":"Ge","year":"2006","journal-title":"Heart"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCHEARTFAILURE.108.843243","article-title":"Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction","volume":"3","author":"Assmus","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ejechocard\/jeq116","article-title":"Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: A 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study","volume":"12","author":"Beitnes","year":"2011","journal-title":"Eur. J. Echocardiogr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacc.2007.10.032","article-title":"Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: Safety, clinical outcome, and serial changes in left ventricular function during 12-months\u2019 follow-up","volume":"51","author":"Lunde","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/eurheartj\/ehn436","article-title":"Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction","volume":"29","author":"Huikuri","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2009.02.051","article-title":"The BALANCE Study: Clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction","volume":"53","author":"Yousef","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00392-013-0595-9","article-title":"Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: Final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial","volume":"102","author":"Wohrle","year":"2013","journal-title":"Clin. Res. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/eurheartj\/ehq455","article-title":"Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: Results of the randomized multicenter BONAMI trial","volume":"32","author":"Roncalli","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"385124","DOI":"10.1155\/2011\/385124","article-title":"One-Year safety analysis of the COMPARE-AMI Trial: Comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular eysfunction","volume":"2011","author":"Mansour","year":"2011","journal-title":"Bone Marrow Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: The TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/j.ijcard.2013.08.032","article-title":"Two year follow-up results of the CARDIAC (CARDIomyoplasty by Autologous intraCoronary bone marrow in acute myocardial infarction) randomised controlled trial","volume":"168","author":"Piepoli","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jacc.2005.01.069","article-title":"Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: The IACT Study","volume":"46","author":"Strauer","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","article-title":"Transcoronary transplantation of progenitor cells after myocardial infarction","volume":"355","author":"Assmus","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/eurjhf\/hfq095","article-title":"The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: The STAR-heart study","volume":"12","author":"Strauer","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/eurheartj\/ehm629","article-title":"Prevalence of positive ECG criteria in young competitive athletes: A single region experience","volume":"29","author":"Martin","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.111.067785","article-title":"Cell therapy in chagas cardiomyopathy (Chagas Arm of the Multicenter Randomized Trial of Cell Therapy in Cardiopathies Study): A multicenter randomized trial","volume":"125","author":"Rassi","year":"2012","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2009.11.070","article-title":"The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial a long-term follow-up study","volume":"55","author":"Seth","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2006.07.057","article-title":"Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: Clinical and histopathological results: The first-in-man ABCD (Autologous bone marrow cells in dilated cardiomyopathy) trial","volume":"48","author":"Seth","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1399-3046.2008.01024.x","article-title":"Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy","volume":"13","author":"Rupp","year":"2009","journal-title":"Pediatr. Transpl."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.healun.2009.10.006","article-title":"A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells","volume":"29","author":"Rupp","year":"2010","journal-title":"J. Heart Lung Transpl."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1017\/S1047951112000066","article-title":"Intracoronary bone marrow cell application for terminal heart failure in children","volume":"22","author":"Rupp","year":"2012","journal-title":"Cardiol. Young"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1399-3046.2009.01215.x","article-title":"Peripheric stem cell transplantation in children with dilated cardiomyopathy: Preliminary report of first two cases","volume":"14","author":"Olgunturk","year":"2010","journal-title":"Pediatr. Transpl."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1017\/S1047951110001435","article-title":"Intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill child with dilated cardiomyopathy","volume":"21","author":"Lacis","year":"2011","journal-title":"Cardiol. Young"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/petr.12055","article-title":"Follow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy","volume":"17","author":"Bergmane","year":"2013","journal-title":"Pediatr. Transpl."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1002\/clc.20463","article-title":"Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: First pediatric experience","volume":"33","author":"Limsuwan","year":"2010","journal-title":"Clin. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jtcvs.2014.10.093","article-title":"Regenerative therapy for hypoplastic left heart syndrome: First report of intraoperative intramyocardial injection of autologous umbilical-cord blood\u2013derived cells","volume":"149","author":"Burkhart","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1198.e2","DOI":"10.1016\/j.jtcvs.2015.06.076","article-title":"Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial","volume":"150","author":"Tarui","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5966\/sctm.2014-0195","article-title":"Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system","volume":"4","author":"Burkhart","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"585.e4","DOI":"10.1016\/j.athoracsur.2009.10.035","article-title":"Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training","volume":"89","author":"Davies","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13287-015-0044-y","article-title":"Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload","volume":"6","author":"Oommen","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3727\/096368909X471170","article-title":"Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload","volume":"18","author":"Yerebakan","year":"2009","journal-title":"Cell Transpl."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrcardio.2014.9","article-title":"Cell therapy for cardiac repair\u2014Lessons from clinical trials","volume":"11","author":"Behfar","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.175943","article-title":"Aging and disease as modifiers of efficacy of cell therapy","volume":"102","author":"Dimmeler","year":"2008","journal-title":"Circ. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1161\/01.RES.0000020861.20064.7E","article-title":"Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function","volume":"90","author":"Edelberg","year":"2002","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","article-title":"Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart","volume":"105","author":"Toma","year":"2002","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/CS20120641","article-title":"Stem cell stimulation of endogenous myocyte regeneration","volume":"125","author":"Weil","year":"2013","journal-title":"Clin. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.yjmcc.2011.05.015","article-title":"Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration","volume":"51","author":"Schulman","year":"2011","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/3\/3\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:25:30Z","timestamp":1760210730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/3\/3\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,5]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,9]]}},"alternative-id":["jcdd3030024"],"URL":"https:\/\/doi.org\/10.3390\/jcdd3030024","relation":{},"ISSN":["2308-3425"],"issn-type":[{"type":"electronic","value":"2308-3425"}],"subject":[],"published":{"date-parts":[[2016,7,5]]}}}